Solarvest BioEnergy Inc.
TSX VENTURE : SVS

Solarvest BioEnergy Inc.

October 13, 2009 19:09 ET

Solarvest BioEnergy Inc. Announces the Appointment of William (Bill) Cheliak to Its Board of Directors

VANCOUVER, BRITISH COLUMBIA--(Marketwire - Oct. 13, 2009) - SOLARVEST BIOENERGY INC. (TSX VENTURE:SVS) ("Solarvest" or the "Company") wishes to announce the appointment of William (Bill) Cheliak to its board of directors.

Mr. Cheliak has over 20 years of experience in a wide variety of biotechnology fields, including vaccines, human genetics, drug development, manufacturing and extensive interactions with the pharmaceutical industry. Over the past decade, Mr. Cheliak has secured deals with big and small Pharma totalling more than $500M. He has executed numerous technology access deals and with academic institutions and research hospitals.

About Solarvest

Solarvest is a research and development company in the biotechnology sector. The Company is committed to the development of sustainable and renewable energy sources to meet growing energy demands and environmental challenges. Solarvest has acquired the rights to a biologically-based hydrogen producing technology, which provides a controlled method for turning on and off genes in algae resulting in the continuous production of hydrogen gas.

The statements made in this Press Release may contain forward-looking statements that may involve a number of risks and uncertainties. Actual events or results could differ materially from the Company's expectations and projections.

The TSX Venture Exchange has neither approved nor disapproved the contents of this Press Release. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Contact Information

  • Solarvest BioEnergy Inc.
    Kenneth A. Cawkell
    Chairman
    (604) 684-3323 ext 227
    (604) 684-3350 (FAX)
    kcawkell@cawkell.com